Mid-Sized Bard Delivers Solid Growth In Device Landscape Of Giants, Infants

Bard aims to rely on execution in niche areas where it can comfortably sustain market leadership to deliver sustainable double-digit revenue growth, according to President & CEO Tim Ring

More from Archive

More from Medtech Insight